UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN

Oncotarget, 2015-10, Vol.6 (30), p.30239-30250

2015

Volltextzugriff (PDF)

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study

The oncologist (Dayton, Ohio), 2019-02, Vol.24 (2), p.157-e64

2019

Volltextzugriff (PDF)

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

Journal of international medical research, 2020-04, Vol.48 (4), p.300060519887275-300060519887275

2020

Volltextzugriff (PDF)

Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy

Journal of translational medicine, 2022-09, Vol.20 (1), p.1-432, Article 432

2022

Volltextzugriff (PDF)

Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial

BMC cancer, 2021-06, Vol.21 (1), p.1-721, Article 721

2021

Volltextzugriff (PDF)

Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study)

BMC cancer, 2022-03, Vol.22 (1), p.294-294, Article 294

2022

Volltextzugriff (PDF)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas

Frontiers in genetics, 2022-07, Vol.13, p.905751-905751

2022

Volltextzugriff (PDF)

Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer

Frontiers in genetics, 2021-09, Vol.12, p.722078-722078

2021

Volltextzugriff (PDF)

Extracellular vesicle miRNAs for predicting the efficacy of late-line treatment with anlotinib in patients with lung adenocarcinoma

Cancer nanotechnology, 2024-12, Vol.15 (1), p.35-13, Article 35

2024

Volltextzugriff (PDF)

Mutational Analysis of OCT4+ and OCT4− Circulating Tumour Cells by Single Cell Whole Exome Sequencing in Stage I Non-Small Cell Lung Cancer Patients

Shanghai jiao tong da xue xue bao, 2021-02, Vol.26 (1), p.40-46

2021

Volltextzugriff (PDF)

Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients

Oncotarget, 2017-09, Vol.8 (38), p.63846-63856

2017

Volltextzugriff (PDF)

Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive‐stage small‐cell lung cancer patients (DURABLE study)

The clinical respiratory journal, 2023-12, Vol.17 (12), p.1361-1367

2023

Volltextzugriff (PDF)

A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2014-11, Vol.86 (2), p.207-212

2014

Volltextzugriff (PDF)

Deletion of the low-molecular-weight glutenin subunit allele Glu-A3a of wheat (Triticum aestivum L.) significantly reduces dough strength and breadmaking quality

BMC plant biology, 2014-12, Vol.14 (1), p.367-367, Article 367

2014

Volltextzugriff (PDF)

Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer

Advanced science, 2019-10, Vol.6 (19), p.1900721-n/a

2019

Volltextzugriff (PDF)

Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study

BMC cancer, 2024-06, Vol.24 (1), p.715-715

2024

Volltextzugriff (PDF)

Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation Study

JMIR cancer, 2024-06, Vol.10, p.e45331

2024

Volltextzugriff (PDF)

Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer

Chinese journal of cancer research, 2013-02, Vol.25 (1), p.90-94

2013

Volltextzugriff (PDF)

Association of XPD Polymorphisms with Severe Toxicity in Non-Small Cell Lung Cancer Patients in a Chinese Population

Clinical cancer research, 2009-06, Vol.15 (11), p.3889-3895

2009

Volltextzugriff (PDF)

Polymeric micellar paclitaxel (Pm-Pac) prolonged overall survival for NSCLC patients without pleural metastasis

International journal of pharmaceutics, 2022-07, Vol.623, p.121961-121961, Article 121961

2022

Volltextzugriff (PDF)

Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort study

Medicine (Baltimore), 2020-10, Vol.99 (41), p.e22678-e22678

2020

Volltextzugriff (PDF)

An integrative proteome analysis of different seedling organs in tolerant and sensitive wheat cultivars under drought stress and recovery

Proteomics (Weinheim), 2015-05, Vol.15 (9), p.1544-1563

2015

Volltextzugriff (PDF)

B cells enhance EphA2 chimeric antigen receptor T cells cytotoxicity against glioblastoma via improving persistence

Human immunology, 2024-11, Vol.85 (6), p.111093, Article 111093

2024

Volltextzugriff (PDF)

Clinical Experience with First-generation Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients  with Brain Metastasis

Zhongguo fei ai za zhi, 2017-02, Vol.20 (2), p.114-123

2017

Volltextzugriff (PDF)

Analysis of Survival Predictors in Patients with Lung Cancer and Brain Metastases

Zhongguo fei ai za zhi, 2015-07, Vol.18 (7), p.436-442

2015

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(141)
Buchkapitel
(1)

Sprache

Englisch
(126)
Chinesisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(93)
Life Sciences & Biomedicine
(77)
Humans
(43)
Oncology
(32)
Lung Cancer
(29)
Female
(28)
Male
(28)
Middle Aged
(22)
Adult
(20)
Aged
(17)
Mutation
(16)
Non-Small Cell Lung Cancer
(16)
Physical Sciences
(16)
Respiratory System
(16)
Chemistry
(15)
Chemotherapy
(15)
Lung Neoplasms - Drug Therapy
(15)
Animals
(14)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(13)
Lung Neoplasms - Pathology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy

Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial

Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas

Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer

Extracellular vesicle miRNAs for predicting the efficacy of late-line treatment with anlotinib in patients with lung adenocarcinoma

Mutational Analysis of OCT4+ and OCT4− Circulating Tumour Cells by Single Cell Whole Exome Sequencing in Stage I Non-Small Cell Lung Cancer Patients

Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients

Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive‐stage small‐cell lung cancer patients (DURABLE study)

A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)

Deletion of the low-molecular-weight glutenin subunit allele Glu-A3a of wheat (Triticum aestivum L.) significantly reduces dough strength and breadmaking quality

Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer

Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study

Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation Study

Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer

Association of XPD Polymorphisms with Severe Toxicity in Non-Small Cell Lung Cancer Patients in a Chinese Population

Polymeric micellar paclitaxel (Pm-Pac) prolonged overall survival for NSCLC patients without pleural metastasis

Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort study

An integrative proteome analysis of different seedling organs in tolerant and sensitive wheat cultivars under drought stress and recovery

B cells enhance EphA2 chimeric antigen receptor T cells cytotoxicity against glioblastoma via improving persistence

Clinical Experience with First-generation Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients  with Brain Metastasis

Analysis of Survival Predictors in Patients with Lung Cancer and Brain Metastases

Suchergebnisse filtern